Decreased Akt hyperactivation properties of Nef-G63E mutant SIV.
(A) Plasma ferritin levels (ng/ml) in examined NAb non-inducers versus Nef-G63E mutant SIV-selecting NAb inducers around year 1 post-infection. Bars represent mean in each group. Compared by unpaired t test.
(B) Relative levels of pAkt Ser473 (left panel) and threonine (Thr) 308 (right panel) in SIV Nef+ HSR5.4 cells (MOI 0.1, 4 days p.i.).
(C) Relative pAkt Ser473 levels in Nef+ HSC-F cells without stimuli and transiently pulsed with IFN-γ, IL-2 or SIVmac Env gp130 after infection (MOI 0.2, 1 day).
(D) Gene expression significantly differing between WT and Nef-G63E SIV infection (MOI 5, 1 day). Black bars show potentially Akt-related genes. Asterisks show dynamics concordant with the Nef-G63E phenotype (PI3K-pAkt Ser473 downstream downregulation or inhibition upregulation).
(E) Representative flow cytometric gating (NAb inducer R01-012, wk 30 p.i.) of peripheral blood CXCR3-CXCR5+PD-1+ memory follicular CD4+ T cells. Cells were gated as CD3+CD8-CD4+CD95+CXCR5+PD-1+CXCR3- live singlet PBMCs. Available samples of six NAb inducers showing peak Nef-G63E mutant selection around week 30 p.i. and thirteen viremic NAb non-inducers were tracked.
(F) Comparison of peripheral CXCR3-CXCR5+PD-1+ memory Tfh cell frequencies between pre-SIV infection and around week 30 post-infection in NAb non-inducers developing disease before week 60 (left: n = 5) and alive more than 70 weeks (middle: n = 8) and Nef-G63E-detected NAb inducers alive more than 70 weeks (right: n = 6). Analyzed by Wilcoxon signed-rank tests.
MFIs relative to those in uninfected controls (%) are shown. **: P < 0.01, ***: P < 0.001, n.s.: not significant between WT and Nef-G63E mutant by unpaired t tests (B-C). Data represent one of two (B, C) independent experiments performed in triplicate (C: unstimulated) or quadruplicate (B, C: PI3K-pulsed). Bars: mean ± SEM.